colorectal cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 3.1 Stage II-IV colorectal cancer with definite pathological and cytological diagnosis; 3.2 Patients receiving chemotherapy regimens; 3.3 Age: 18-75 years, patients with an estimated survival of>6 months; 3.4 KPS =60 points; 3.5 Patients who have undergone surgery 3.6 Voluntary participation and signing of informed consent.
Exclusion criteria
Exclusion criteria: 4.1 Those who are participating in or have participated in clinical trials of other drugs within 4 weeks; 4.2 Pregnant and lactating women 4.3 Evidence of severe or uncontrolled systemic disease (e.g., unstable or uncompensated respiratory, cardiac, hepatic or renal disease) or psychiatric disorders.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| TCM Syndrome Evaluation Scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| Complete Blood Count;Comprehensive Metabolic Panel;Routine coagulation tests;European Organisation for Research and Treatment of Cancer;Chalder's Fatigue Scale;Athens Insomnia Scale;KarnofskyPerformance Status;Patient Health Questionnaire-9;Generalized anxiety disorder-7;Research on conceptual framework of PRO scale in spleen Qi deficiency syndrome; | — |
Countries
China
Contacts
Shuguang Hospital Shanghai University of Traditional Chinese Medicine